- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GlaxoSmithKline PLC (G1SK34)Assess today's live GlaxoSmithKline PLC (G1SK34) share price, performance and insights using our live B3: G1SK34 stock exchange data.
Analyse the historical data and GlaxoSmithKline PLC share price performance charts on this page. Our technical summary section provides analysis on GlaxoSmithKline share price buy/sell indicators using real-time data (or discuss the GlaxoSmithKline (G1SK34) stock price today with other investors in the GlaxoSmithKline BVMF share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current BVMF G1SK34 share price (ISIN: BRG1SKBDR008) to enhance your trading decisions with our free investment tools and resources.
What Is the GlaxoSmithKline PLC Share Price Today?
The GlaxoSmithKline share price today is 41.00.
What Is the Stock Symbol for GlaxoSmithKline PLC
The stock symbol (or 'ticker') for GlaxoSmithKline PLC is "G1SK34."
What Stock Exchange Does GlaxoSmithKline PLC Trade On?
GlaxoSmithKline PLC is listed and trades on the B3 stock exchange.
Is GlaxoSmithKline PLC a Good Stock to Buy?
Determining whether GlaxoSmithKline PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and GlaxoSmithKline PLC share price performance charts on this page. Our technical summary section provides analysis on GlaxoSmithKline share price buy/sell indicators using real-time data (or discuss the GlaxoSmithKline (G1SK34) stock price today with other investors in the GlaxoSmithKline BVMF share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current BVMF G1SK34 share price (ISIN: BRG1SKBDR008) to enhance your trading decisions with our free investment tools and resources.
What Is the GlaxoSmithKline PLC Share Price Today?
The GlaxoSmithKline share price today is 41.00.
What Is the Stock Symbol for GlaxoSmithKline PLC
The stock symbol (or 'ticker') for GlaxoSmithKline PLC is "G1SK34."
What Stock Exchange Does GlaxoSmithKline PLC Trade On?
GlaxoSmithKline PLC is listed and trades on the B3 stock exchange.
Is GlaxoSmithKline PLC a Good Stock to Buy?
Determining whether GlaxoSmithKline PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
41.00
-0.72(-1.73%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.00
41.00
52 wk Range
34.01
49.62
G1SK34 Scorecard
Full Analysis
High shareholder yield
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.0041.00
52 wk Range
34.0149.62
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.99%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.99%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
G1SK34 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
- Glaxosmithkline receives Investment Bank Analyst Rating Update
- Investing.com
Pro - FTSE 100 Live: Stocks on firm footing, house prices fall, Boohoo raises cash
- Proactive Investors
- Glaxosmithkline receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Glaxosmithkline receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Glaxosmithkline receives Investment Bank Analyst Rating Update
- Investing.com
Pro
GlaxoSmithKline Company Profile
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson’s disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.
Compare G1SK34 to Peers and Sector
Metrics to compare | G1SK34 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipG1SK34PeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.7x | 16.1x | −0.6x | |
PEG Ratio | −0.37 | 0.14 | 0.00 | |
Price/Book | 3.9x | 1.9x | 2.6x | |
Price / LTM Sales | 1.7x | 2.5x | 3.2x | |
Upside (Analyst Target) | - | 24.5% | 45.4% | |
Fair Value Upside | Unlock | 14.2% | 7.7% | Unlock |
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.617
Dividend Yield
3.92%
Industry Median 1.73%
Annualised payout
1.6366
Paid unevenly
5-Years Growth
-
Growth Streak
People Also Watch
FAQ
What Is the GlaxoSmithKline (G1SK34) Stock Price Today?
The GlaxoSmithKline stock price today is 41.00
What Stock Exchange Does GlaxoSmithKline Trade On?
GlaxoSmithKline is listed and trades on the B3 stock exchange.
What Is the Stock Symbol for GlaxoSmithKline?
The stock symbol for GlaxoSmithKline is "G1SK34."
Does GlaxoSmithKline Pay Dividends? What’s The Current Dividend Yield?
The GlaxoSmithKline dividend yield is 3.99%.
What Is the GlaxoSmithKline Market Cap?
As of today, GlaxoSmithKline market cap is 419.03B.
What is GlaxoSmithKline Earnings Per Share?
The GlaxoSmithKline EPS is 0.617.
From a Technical Analysis Perspective, Is G1SK34 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.